Adrie Christophe, Lugosi Maxime, Sonneville Romain, Souweine Bertrand, Ruckly Stéphane, Cartier Jean-Charles, Garrouste-Orgeas Maité, Schwebel Carole, Timsit Jean-François
Physiology Department, Cochin University Hospital, AP-HP, Paris Descartes University, 27 rue du Faubourg Saint Jacques, 75014, Paris, France.
Polyvalent ICU, Delafontaine Hospital, Saint-Denis, France.
Ann Intensive Care. 2017 Dec;7(1):30. doi: 10.1186/s13613-017-0242-0. Epub 2017 Mar 17.
Severely ill patients might develop an alteration of their immune system called post-aggressive immunosuppression. We sought to assess the risk of ICU-acquired infection and of mortality according to the absolute lymphocyte count at ICU admission and its changes over 3 days.
Adults in ICU for at least 3 days with a shock or persistent low blood pressure were extracted from a French ICU database and included. We evaluated the impact of the absolute lymphocyte count at baseline and its change at day 3 on the incidence of ICU-acquired infection and on the 28-day mortality rate. We categorized lymphocytes in 4 groups: above 1.5 × 10 cells/µL; between 1 and 1.5 × 10 cells/µL; between 0.5 and 1 × 10 cells/µL; and below 0.5 × 10 cells/µL.
A total of 753 patients were included. The median lymphocyte count was 0.8 × 10 cells/µL [0.51-1.29]. A total of 174 (23%) patients developed infections; the 28-day mortality rate was 21% (161/753). Lymphopenia at admission was associated with ICU-acquired infection (p < 0.001) but not with 28-day mortality. Independently of baseline lymphocyte count, the absence of lymphocyte count increase at day 3 was associated with ICU-acquired infection (sub-distribution hazard ratio sHR: 1.37 [1.12-1.67], p = 0.002) and with 28-day mortality (sHR: 1.67 [1.37-2.03], p < 0.0001).
Lymphopenia at ICU admission and its persistence at day 3 were associated with an increased risk of ICU-acquired infection, while only persisting lymphopenia predicted increased 28-day mortality. The lymphocyte count at ICU admission and at day 3 could be used as a simple and reproductive marker of post-aggressive immunosuppression.
重症患者可能会出现一种称为侵袭后免疫抑制的免疫系统改变。我们试图根据重症监护病房(ICU)入院时的绝对淋巴细胞计数及其3天内的变化来评估ICU获得性感染和死亡风险。
从法国ICU数据库中提取并纳入在ICU至少住院3天且患有休克或持续性低血压的成年人。我们评估了基线时的绝对淋巴细胞计数及其第3天的变化对ICU获得性感染发生率和28天死亡率的影响。我们将淋巴细胞分为4组:高于1.5×10⁹细胞/µL;介于1×10⁹和1.5×10⁹细胞/µL之间;介于0.5×10⁹和1×10⁹细胞/µL之间;以及低于0.5×10⁹细胞/µL。
共纳入753例患者。淋巴细胞计数中位数为0.8×10⁹细胞/µL[0.51 - 1.29]。共有174例(23%)患者发生感染;28天死亡率为21%(161/753)。入院时淋巴细胞减少与ICU获得性感染相关(p < 0.001),但与28天死亡率无关。与基线淋巴细胞计数无关,第3天淋巴细胞计数未增加与ICU获得性感染相关(亚分布风险比sHR:1.37[1.12 - 1.67],p = 0.002)以及与28天死亡率相关(sHR:1.67[1.37 - 2.03],p < 0.0001)。
ICU入院时淋巴细胞减少及其在第3天持续存在与ICU获得性感染风险增加相关,而只有持续性淋巴细胞减少预示28天死亡率增加。ICU入院时和第3天的淋巴细胞计数可作为侵袭后免疫抑制的简单且可重复的标志物。